$ADTX 8-K/A SEC Filings

The accompanying notes are an integral part of these unaudited pro forma consolidated financial statements.

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant wa...

See accompanying notes to the condensed consolidated financial statements (unaudited).

The accompanying notes are an integral part to these unaudited pro forma consolidated financial statements.

We have audited the accompanying consolidated balance sheets of Evofem Biosciences, Inc. and Subsidiaries (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of operations, comprehensive operations, ...

See accompanying notes to the condensed consolidated financial statements (unaudited).

Pro Forma Consolidated Statement of Financial Position (Unaudited) (In thousands of U.S. dollars) As of September 30, 2024

The accompanying notes are an integral part to these unaudited pro forma consolidated financial statements.

The accompanying notes are an integral part to these unaudited pro forma consolidated financial statements.

We have audited the accompanying consolidated balance sheet of Evofem Biosciences, Inc. and Subsidiaries (the “Company”) as of December 31, 2023, and the related consolidated statements of operations, comprehensive operations, convertibl...

The accompanying notes are an integral part to these unaudited pro forma consolidated financial statements.

On December 22, 2023, Aditxt, Inc. (the “Company”) entered into an Exchange Agreement (the “Exchange Agreement”) with the holders (the “Holders”) of an aggregate of 22,280 shares of Series F-1 Convertible Preferred Stock of Evofem Biosci...

THIS REINSTATEMENT AND FOURTH AMENDMENT TO MERGER AGREEMENT AND WAIVER AGREEMENT, dated as of May 2, 2024 (this “Reinstatement and Amendment”), to that certain Agreement and Plan of Merger dated as of December 11, 2023 (as amended hereby...

† Certain of the schedules (and/or exhibits) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule (and/or exhibit) will be furnished to the SEC upon request